Trial Profile
Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT (intravaginal ejaculatory latency time) measured by stop watch in male patients with premature ejaculation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2016
Price :
$35
*
At a glance
- Drugs Clomipramine (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors Vectura
- 20 Jul 2016 Status changed from active, no longer recruiting to completed.
- 05 Nov 2010 New trial record.